Celsius Holdings, Inc.

Celsius Holdings, Inc. (CELH) Stock Analysis

$28.160

+1.025 (+3.64%)At close

Loading chart…
High
28.330
Open
27.320
VWAP
27.94
Volume
6.15M
Mkt Cap
13.41B
Low
27.320
Amount
171.88M
EV/EBITDA, TTM
9.96

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.

AI analysis of Celsius Holdings, Inc. (CELH)

Hold

Celsius Holdings Inc is currently priced at $28.58, which is below the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E of 16.86, suggesting it may be overvalued given its recent performance, with a year-to-date change of -40.15%. Additionally, the RSI is at 65.16, indicating it is nearing overbought territory. The main risk is the recent class action lawsuit, which could negatively impact investor sentiment.

Analyst Ratings (1)

+123.19% upside
Buy
1 Buy
0 Hold
0 Sell
Current: 28.16
Low
45.00
Average
62.85
High
80.00

Morgan Stanley

2026-09-17

Price Target

$42

Overweight

Deutsche Bank

2026-08-27

Price Target

$35

Hold

Goldman Sachs

2026-08-10

Price Target

$45

Buy

Stephens

2026-08-10

Price Target

$50

Overweight

Morgan Stanley

2026-08-07

Price Target

$42

Overweight

Valuation Metrics

The current forward P/E ratio for Celsius Holdings, Inc. (CELH) is 16.86, compared to its 5-year average forward P/E of 66.00.

Forward P/E

Fair
5Y Average P/E
66.00
Current P/E
16.86
Overvalued
123.59
Undervalued
8.41

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
39.95
Current EV/EBITDA
9.96
Overvalued
65.21
Undervalued
14.68

Forward P/S

Undervalued
5Y Average P/S
6.38
Current P/S
2.00
Overvalued
9.47
Undervalued
3.28

Alphio AI Price Scenarios for CELH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CELH

$36.73

Scenario price

B

Base

Base · 50%CELH

$34.22

Scenario price

B

Bear

Bear · 25%CELH

$28.13

Scenario price

Whales holding CELH

C

Champlain Investment Partners, LLC

+ HoldingCELH

+4.06%

3M Return

I

Infrastructure Capital Advisors, LLC

+ HoldingCELH

-3.58%

3M Return

V

Voss Capital, LP

+ HoldingCELH

-3.81%

3M Return

D

Divisadero Street Capital Management, LP

+ HoldingCELH

-13.75%

3M Return

S

Sachem Head Capital Management LP

+ HoldingCELH

-14.35%

3M Return

Events Timeline

2026-08-31 (ET)

09:30:00

Celsius Named Official Energy Drink Sponsor of ESPN College GameDay

2026-08-27 (ET)

16:30:00

Nvidia's Quarterly Report Drives Tech Stocks Higher

12:30:00

Nasdaq Rises 350.95 Points on Nvidia Earnings

2026-08-10 (ET)

16:30:00

Celsius Holdings Appoints New Executives to Drive Business Transformation

2026-08-07 (ET)

12:00:00

Celsius Shares Rise 12% to $26.61

News

CELH FAQ — answered by Alphio AI

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).

Celsius Holdings Inc is currently priced at $28.58, which is below the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E of 16.86, suggesting it may be overvalued given its recent performance, with a year-to-date change of -40.15%. Additionally, the RSI is at 65.16, indicating it is nearing overbought territory. The main risk is the recent class action lawsuit, which could negatively impact investor sentiment.

1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.

Community

More ↗
0xSkewfalcon2 days ago

$CELH could realistically consolidate until June 2027. It has about 8 months of room left before it reaches the apex of this massive symmetrical triangle, before it could break out and start the next bull run or leg up. Not financial advice, just food for thought. Shares are probably the best way to go to avoid theta decay.

Show more
Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading